688265 南模生物
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.0570.380-1.175-0.3045.971
总资产报酬率 ROA (%)-0.0500.331-1.016-0.2695.244
投入资产回报率 ROIC (%)-0.0520.344-1.056-0.2805.550

边际利润分析
销售毛利率 (%)48.98445.63942.37841.74460.865
营业利润率 (%)-2.5340.731-8.130-5.40424.649
息税前利润/营业总收入 (%)-1.8811.001-7.195-5.61825.096
净利润/营业总收入 (%)-1.0941.704-5.615-1.78222.110

收益指标分析
经营活动净收益/利润总额(%)267.635-643.137132.267226.04088.892
价值变动净收益/利润总额(%)-241.353745.553-60.227-123.8783.300
营业外收支净额/利润总额(%)2.188-2.1750.342-11.2601.765

偿债能力分析
流动比率 (X)6.9866.5556.4797.47112.220
速动比率 (X)6.8906.4836.3917.36912.116
资产负债率 (%)11.92912.76913.06414.0129.185
带息债务/全部投入资本 (%)5.2455.3495.4585.1773.410
股东权益/带息债务 (%)1,740.4611,697.5671,654.9621,726.5342,776.211
股东权益/负债合计 (%)738.296683.158665.472613.699988.743
利息保障倍数 (X)-2.6513.506-7.4747.3816,302.691

营运能力分析
应收账款周转天数 (天)125.642103.94598.54487.96870.610
存货周转天数 (天)28.41924.75128.06432.75144.717